INO:NASDAQ
Inovio Pharmaceuticals
1,64 USD
arrow_upward
+0,61%(+0,0100) 1D
18. stu, 13:28:27 GMT -5 · USD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za INO...
Otvori
1,64 USD
Najviša
1,67 USD
Najniža
1,56 USD
Trž. kap.
307,18 mil.
Prosj. kol.
19,92 mil.
Količina
5,75 mil.
52-tjed. najviša
2,72 USD
52-tjed. najniža
0,57 USD
EPS
−0,80 USD
Beta
1,71
Dionice u optjecaju
187,31 mil.
Broj djelatnika
112
Otvori
1,64 USD
Najviša
1,67 USD
Najniža
1,56 USD
Trž. kap.
307,18 mil.
Prosj. kol.
19,92 mil.
Količina
5,75 mil.
52-tjed. najviša
2,72 USD
52-tjed. najniža
0,57 USD
EPS
−0,80 USD
Beta
1,71
Dionice u optjecaju
187,31 mil.
Broj djelatnika
112
Vijesti
Iz web-izvora i od partnera za vijesti
Investing.com
·
prije 5 sati
Inovio submits European approval application for RRP treatment
Yahoo Finance
·
prije 15 sati
Inovio Pharmaceuticals (INO) Stock Gets Fair Value Boost After VOCERYQ Approval
The Business Journals
·
prije 1 dan
After 43 years, Inovio gets its first FDA-approved drug in 'milestone' decision
Profil
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
Inovio Pharmaceuticals – informacije
Glavni izvršni direktorJacqueline Shea
Zaposlenici112
Osnovano1999
Sjedište-
SektorHealth Care
Djelatnost-
Web-lokacijainovio.com